BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

101 related articles for article (PubMed ID: 20804738)

  • 1. Cleavage by MALT1 induces cytosolic release of A20.
    Malinverni C; Unterreiner A; Staal J; Demeyer A; Galaup M; Luyten M; Beyaert R; Bornancin F
    Biochem Biophys Res Commun; 2010 Oct; 400(4):543-7. PubMed ID: 20804738
    [TBL] [Abstract][Full Text] [Related]  

  • 2. A20 negatively regulates T cell receptor signaling to NF-kappaB by cleaving Malt1 ubiquitin chains.
    Düwel M; Welteke V; Oeckinghaus A; Baens M; Kloo B; Ferch U; Darnay BG; Ruland J; Marynen P; Krappmann D
    J Immunol; 2009 Jun; 182(12):7718-28. PubMed ID: 19494296
    [TBL] [Abstract][Full Text] [Related]  

  • 3. T cell antigen receptor stimulation induces MALT1 paracaspase-mediated cleavage of the NF-kappaB inhibitor A20.
    Coornaert B; Baens M; Heyninck K; Bekaert T; Haegman M; Staal J; Sun L; Chen ZJ; Marynen P; Beyaert R
    Nat Immunol; 2008 Mar; 9(3):263-71. PubMed ID: 18223652
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Alternative expression pattern of MALT1-A20-NF-κB in patients with rheumatoid arthritis.
    Wang X; Zhu L; Liao Z; Zhang F; Xu L; Xu Y; Chen S; Yang L; Zhou Y; Li Y
    J Immunol Res; 2014; 2014():492872. PubMed ID: 24971370
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Two Antagonistic MALT1 Auto-Cleavage Mechanisms Reveal a Role for TRAF6 to Unleash MALT1 Activation.
    Ginster S; Bardet M; Unterreiner A; Malinverni C; Renner F; Lam S; Freuler F; Gerrits B; Voshol J; Calzascia T; Régnier CH; Renatus M; Nikolay R; Israël L; Bornancin F
    PLoS One; 2017; 12(1):e0169026. PubMed ID: 28052131
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Molecular basis for the unique deubiquitinating activity of the NF-kappaB inhibitor A20.
    Lin SC; Chung JY; Lamothe B; Rajashankar K; Lu M; Lo YC; Lam AY; Darnay BG; Wu H
    J Mol Biol; 2008 Feb; 376(2):526-40. PubMed ID: 18164316
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The zinc finger protein A20 interacts with a novel anti-apoptotic protein which is cleaved by specific caspases.
    De Valck D; Jin DY; Heyninck K; Van de Craen M; Contreras R; Fiers W; Jeang KT; Beyaert R
    Oncogene; 1999 Jul; 18(29):4182-90. PubMed ID: 10435631
    [TBL] [Abstract][Full Text] [Related]  

  • 8. A20 inhibits oxidized low-density lipoprotein-induced apoptosis through negative Fas/Fas ligand-dependent activation of caspase-8 and mitochondrial pathways in murine RAW264.7 macrophages.
    Li HL; Wang AB; Zhang R; Wei YS; Chen HZ; She ZG; Huang Y; Liu DP; Liang CC
    J Cell Physiol; 2006 Aug; 208(2):307-18. PubMed ID: 16646083
    [TBL] [Abstract][Full Text] [Related]  

  • 9. TRAF2-binding BIR1 domain of c-IAP2/MALT1 fusion protein is essential for activation of NF-kappaB.
    Garrison JB; Samuel T; Reed JC
    Oncogene; 2009 Apr; 28(13):1584-93. PubMed ID: 19234489
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Detection of recombinant and cellular MALT1 paracaspase activity.
    Nagel D; Krappmann D
    Methods Mol Biol; 2015; 1280():239-46. PubMed ID: 25736752
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The ubiquitin-editing enzyme A20 (TNFAIP3) is a central regulator of immunopathology.
    Vereecke L; Beyaert R; van Loo G
    Trends Immunol; 2009 Aug; 30(8):383-91. PubMed ID: 19643665
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Probes to monitor activity of the paracaspase MALT1.
    Hachmann J; Edgington-Mitchell LE; Poreba M; Sanman LE; Drag M; Bogyo M; Salvesen GS
    Chem Biol; 2015 Jan; 22(1):139-47. PubMed ID: 25556944
    [TBL] [Abstract][Full Text] [Related]  

  • 13. A20 zinc finger protein inhibits TNF-induced apoptosis and stress response early in the signaling cascades and independently of binding to TRAF2 or 14-3-3 proteins.
    Lademann U; Kallunki T; Jäättelä M
    Cell Death Differ; 2001 Mar; 8(3):265-72. PubMed ID: 11319609
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Malt1 and cIAP2-Malt1 as effectors of NF-kappaB activation: kissing cousins or distant relatives?
    Kingeter LM; Schaefer BC
    Cell Signal; 2010 Jan; 22(1):9-22. PubMed ID: 19772915
    [TBL] [Abstract][Full Text] [Related]  

  • 15. T-cell receptor-induced JNK activation requires proteolytic inactivation of CYLD by MALT1.
    Staal J; Driege Y; Bekaert T; Demeyer A; Muyllaert D; Van Damme P; Gevaert K; Beyaert R
    EMBO J; 2011 May; 30(9):1742-52. PubMed ID: 21448133
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The proteolytic activity of the paracaspase MALT1 is key in T cell activation.
    Rebeaud F; Hailfinger S; Posevitz-Fejfar A; Tapernoux M; Moser R; Rueda D; Gaide O; Guzzardi M; Iancu EM; Rufer N; Fasel N; Thome M
    Nat Immunol; 2008 Mar; 9(3):272-81. PubMed ID: 18264101
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The E3 ligase Itch negatively regulates inflammatory signaling pathways by controlling the function of the ubiquitin-editing enzyme A20.
    Shembade N; Harhaj NS; Parvatiyar K; Copeland NG; Jenkins NA; Matesic LE; Harhaj EW
    Nat Immunol; 2008 Mar; 9(3):254-62. PubMed ID: 18246070
    [TBL] [Abstract][Full Text] [Related]  

  • 18. ABINs: A20 binding inhibitors of NF-kappa B and apoptosis signaling.
    Verstrepen L; Carpentier I; Verhelst K; Beyaert R
    Biochem Pharmacol; 2009 Jul; 78(2):105-14. PubMed ID: 19464428
    [TBL] [Abstract][Full Text] [Related]  

  • 19. MALT1--a universal soldier: multiple strategies to ensure NF-κB activation and target gene expression.
    Afonina IS; Elton L; Carpentier I; Beyaert R
    FEBS J; 2015 Sep; 282(17):3286-97. PubMed ID: 25996250
    [TBL] [Abstract][Full Text] [Related]  

  • 20. A20 inhibits human salivary adenoid cystic carcinoma cells invasion via blocking nuclear factor-kappaB activation.
    Zhang B; Guan CC; Chen WT; Zhang P; Yan M; Shi JH; Qin CL; Yang Q
    Chin Med J (Engl); 2007 Oct; 120(20):1830-5. PubMed ID: 18028781
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.